Novartis Malaria Innovation and Access Journey

More than 20 years ago today, Novartis signed an agreement with World Health Organization to make its antimalarial available without profit to the public sector in malaria-endemic countries. Although the agreement expired in 2011, Novartis continues to provide treatments on the same terms as before. Since then more than 1 billion antimalarials have been delivered in 70+ countries in collaboration with our partners. Track our journey toward malaria elimination.
Learn more: go.novartis.social/3UcmlLX